These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8029886)

  • 41. Effect of antilymphocyte serum-treated bone marrow on skin graft survival in rats.
    Sato T; Amada N; Fujimori K; Sawada H; Satake M; Taguchi Y; Kasai M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):578. PubMed ID: 3274824
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of interleukin-10 on the immunoactivating and immunosuppressive properties of anti-CD3 monoclonal antibody.
    Wissing M; Donckier V; Delvaux A; Abramowicz D; Gérard C; Velu T; Goldman M
    Transplant Proc; 1994 Dec; 26(6):3167-8. PubMed ID: 7998105
    [No Abstract]   [Full Text] [Related]  

  • 43. A new method of bone marrow transplantation leads to extension of skin allograft survival.
    Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
    Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kwon CH; Noh JH; Kim SJ
    Immunol Lett; 2006 Feb; 102(2):215-21. PubMed ID: 16260045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergy of ALS and UV-B in prolongation of primate-to-mouse islet xenograft survival.
    Chabot J; Weber C; Hardy MA; Rivera S; Bailey-Braxton D; Strausberg L; Wood M; Chow J; Pi-Sunyer FX; Reemtsma K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1160-5. PubMed ID: 3103285
    [No Abstract]   [Full Text] [Related]  

  • 48. Low rate of white graft reaction (skin hyperacute rejection) in skin xenografts with recipient preformed antibodies.
    Thomas FT
    Transplant Proc; 1992 Apr; 24(2):544-5. PubMed ID: 1566422
    [No Abstract]   [Full Text] [Related]  

  • 49. Normal rejection of xenografts by strongly deficient B-cell animals (X-linked immunodeficient mice).
    Patselas T; Marchman W; Araneda D; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):494. PubMed ID: 1566401
    [No Abstract]   [Full Text] [Related]  

  • 50. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of simultaneous infusion of donor bone marrow on hamster-to-rat heart xenograft survival.
    Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Yoshioka S; Asahara T; Fukuda Y; Dohi K
    Transplant Proc; 1998 Nov; 30(7):3869-70. PubMed ID: 9838693
    [No Abstract]   [Full Text] [Related]  

  • 52. Transplantation tolerance following conditioning with C1q-affinity anti-Thy-1 monoclonal antibodies.
    Thierfelder S; Kummer U; Schuh R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):459-61. PubMed ID: 3274806
    [No Abstract]   [Full Text] [Related]  

  • 53. Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation.
    Ohdan H; Fukuda Y; Shintaku S; Miyata Y; Tashiro H; Hoshino S; Sumimoto R; Asahara T; Kimura A; Dohi K
    Transplant Proc; 1997; 29(1-2):925-7. PubMed ID: 9123589
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 55. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
    Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of natural antibody on xenogeneic bone marrow engraftment.
    Sykes M; Sachs DH; Aksentijevich I
    Transplant Proc; 1992 Apr; 24(2):497-8. PubMed ID: 1566403
    [No Abstract]   [Full Text] [Related]  

  • 57. Rat parathyroid transplantation. Allograft pretreatment with organ culture and antilymphocyte serum.
    Gough IR; Finnimore M
    Transplantation; 1980 Feb; 29(2):149-52. PubMed ID: 6986687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies in rodents on the use of polyclonal antilymphocyte serum and donor-specific bone marrow to induce specific unresponsiveness to skin allografts.
    Monaco AP
    Transplant Proc; 1991 Aug; 23(4):2061-7. PubMed ID: 1871820
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of prenatally inoculated anti-host MHC monoclonals on hematopoietic (mouse to rat) xenochimerism.
    Ghyselen G; Veys E
    Transplant Proc; 1994 Jun; 26(3):1179. PubMed ID: 7913258
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a nonmyeloablative conditioning regimen.
    Lee LA; Sergio JJ; Sachs DH; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1197-8. PubMed ID: 8029884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.